Glen-and-Val-header

WFH VP Medical Glenn Pierce pays tribute to Val Bias

Glenn Pierce is the Vice President, Medical at the World Federation of Hemophilia (WFH). On December 30, the global bleeding disorders community lost a leader when Val Bias, former CEO of the National Hemophilia Foundation (NHF), passed away. Here, Pierce shares his thoughts on his colleague and friend.

Also available in: Français Español

Glenn Pierce is the Vice President, Medical at the World Federation of Hemophilia (WFH). On December 30, the global bleeding disorders community lost a leader when Val Bias, former CEO of the National Hemophilia Foundation (NHF), passed away. Here, Pierce shares his thoughts on his colleague and friend.

Val Bias and I first got to know each other 30 years ago, when we were both vying to be president of the National Hemophilia Foundation (NHF). I was involved in HIV/AIDS advocacy from within the Board of Directors, and Val was part of a more activist group that felt the NHF wasn’t doing enough. He and I came together, saw our goals were the same, and concluded that we were stronger working together. We teamed up, and he became Chair of the Board while I became the President. Together, with many others we recruited, we evolved the NHF into an organization that was more accountable and that would take a leadership role on HIV/AIDS advocacy. Val subsequently went to Washington, DC (U.S.A) where he led the charge to get the Ricky Ray bill passed, and then worked on making the pharmaceutical industry accountable for their actions. While the financial accountability was important, the highest priority was to understand how the tainted blood scandal happened, and what needed to be done to prevent such a calamity from ever happening again. Val was at the forefront of this fight, which culminated in a report from the National Institute of Medicine on all the failures across the board that allowed HIV (and HCV) to infiltrate the blood supply. This accomplishment is a legacy that endures today.

Val went on to advocate for many of the health and financial issues facing the bleeding disorders community. Our paths crossed often, both nationally and internationally. In 2008, he was selected to lead the NHF as CEO, and, for over 10 years, took the organization to a new level of program offerings and service to the community. By the end of his tenure, the organization was vastly different from the one we had both been involved in initially. Val absolutely loved his job representing his community through the healthcare, advocacy, and political ecosystems.

When Val retired from NHF a couple of years ago, his health issues had begun catching up to him. It isn’t easy living with severe hemophilia. It’s even tougher when your health is compounded by infections and all the sequelae related to bleeds. But Val never let the hemophilia slow him down. In fact, it sped him up—the urgency of the fight was always clear and present in his mind and his actions.

Our hearts go out to Val’s family, who shared this remarkable man with a community that he left a lasting impact upon. I’ve lost a brother—we’ve all lost a brother—in the bleeding disorders community. His spirit of activism, hope and drive will live on in the many individuals he touched during his life.

Click here to read a condolence article from the WFH, and here to read statements from WFH leaders. To read the statement released by NHF, please click here.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.